373 related articles for article (PubMed ID: 28759053)
1. The eukaryotic gut virome in hematopoietic stem cell transplantation: new clues in enteric graft-versus-host disease.
Legoff J; Resche-Rigon M; Bouquet J; Robin M; Naccache SN; Mercier-Delarue S; Federman S; Samayoa E; Rousseau C; Piron P; Kapel N; Simon F; Socié G; Chiu CY
Nat Med; 2017 Sep; 23(9):1080-1085. PubMed ID: 28759053
[TBL] [Abstract][Full Text] [Related]
2. Fecal calprotectin as a biomarker of intestinal graft versus host disease after allogeneic hematopoietic stem cell transplantation.
Lorenz F; Marklund S; Werner M; Palmqvist R; Wahlin BE; Wahlin A
Sci Rep; 2015 Jan; 5():7920. PubMed ID: 25605402
[TBL] [Abstract][Full Text] [Related]
3. Fecal calprotectin and alpha-1 antitrypsin predict severity and response to corticosteroids in gastrointestinal graft-versus-host disease.
Rodriguez-Otero P; Porcher R; Peffault de Latour R; Contreras M; Bouhnik Y; Xhaard A; Andreoli A; Ribaud P; Kapel N; Janin A; Socié G; Robin M
Blood; 2012 Jun; 119(24):5909-17. PubMed ID: 22555971
[TBL] [Abstract][Full Text] [Related]
4. Fecal but not serum calprotectin is a potential marker of GVHD after stem cell transplantation.
Metafuni E; Giammarco S; De Ritis DG; Rossi M; De Michele T; Zuppi C; Bacigalupo AP; Sica S; Chiusolo P
Ann Hematol; 2017 Jun; 96(6):929-933. PubMed ID: 28293713
[TBL] [Abstract][Full Text] [Related]
5. Specific gut microbiome members are associated with distinct immune markers in pediatric allogeneic hematopoietic stem cell transplantation.
Ingham AC; Kielsen K; Cilieborg MS; Lund O; Holmes S; Aarestrup FM; Müller KG; Pamp SJ
Microbiome; 2019 Sep; 7(1):131. PubMed ID: 31519210
[TBL] [Abstract][Full Text] [Related]
6. Graft-Versus-Host Disease in Adolescents and Young Adults (15-24 Years Old) After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Leukemia in First Complete Remission.
Vignon M; Andreoli A; Dhédin N; Lengliné E; Masson E; Robin M; Granier C; Larghero J; Schlageter MH; de Latour RP; Socié G; Boissel N
J Adolesc Young Adult Oncol; 2017 Jun; 6(2):299-306. PubMed ID: 27983886
[TBL] [Abstract][Full Text] [Related]
7. [Gut microbiota and graft-versus-host disease: broad-spectrum antibiotic use increases post-allogeneic hematopoietic stem cell transplant graft-versus-host disease-related mortality].
Shono Y
Rinsho Ketsueki; 2017; 58(7):835-842. PubMed ID: 28781282
[TBL] [Abstract][Full Text] [Related]
8. Endoscopic and Histological Findings Are Predicted by Fecal Calprotectin in Acute Intestinal Graft-Versus-Host-Disease.
Adam B; Koldehoff M; Ditschkowski M; Gromke T; Hlinka M; Trenschel R; Kordeals L; Steckel NK; Beelen DW; Liebregts T
Dig Dis Sci; 2016 Jul; 61(7):2019-26. PubMed ID: 26995779
[TBL] [Abstract][Full Text] [Related]
9. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
[TBL] [Abstract][Full Text] [Related]
10. Human herpesvirus 6 reactivation on the 30th day after allogeneic hematopoietic stem cell transplantation can predict grade 2-4 acute graft-versus-host disease.
Gotoh M; Yoshizawa S; Katagiri S; Suguro T; Asano M; Kitahara T; Akahane D; Okabe S; Tauchi T; Ito Y; Ohyashiki K
Transpl Infect Dis; 2014 Jun; 16(3):440-9. PubMed ID: 24810656
[TBL] [Abstract][Full Text] [Related]
11. Microbiome and diversity indices during blood stem cells transplantation - new perspectives?
Parco S; Benericetti G; Vascotto F; Palmisciano G
Cent Eur J Public Health; 2019 Dec; 27(4):335-339. PubMed ID: 31951695
[TBL] [Abstract][Full Text] [Related]
12. Fecal calprotectin and serum albumin as markers of gastrointestinal graft versus host disease.
Broglie L; Rademaker A; Galvin J; Ray A; Tse WT; Duerst R; Schneiderman J; Kletzel M; Chaudhury S
Hematol Oncol Stem Cell Ther; 2018 Sep; 11(3):169-174. PubMed ID: 29397331
[TBL] [Abstract][Full Text] [Related]
13. Retinoic Acid Signaling Modulates Recipient Gut Barrier Integrity and Microbiota After Allogeneic Hematopoietic Stem Cell Transplantation in Mice.
Pan P; Atkinson SN; Taylor B; Zhu H; Zhou D; Flejsierowicz P; Wang LS; Morse M; Liu C; Gunsolus IL; Chen X
Front Immunol; 2021; 12():749002. PubMed ID: 34759928
[TBL] [Abstract][Full Text] [Related]
14. The Gut Microbiota and Hematopoietic Stem Cell Transplantation: Challenges and Potentials.
Noor F; Kaysen A; Wilmes P; Schneider JG
J Innate Immun; 2019; 11(5):405-415. PubMed ID: 30286447
[TBL] [Abstract][Full Text] [Related]
15. Low-Dose Antithymocyte Globulin for Graft-versus-Host-Disease Prophylaxis in Matched Unrelated Allogeneic Hematopoietic Stem Cell Transplantation.
Bryant A; Mallick R; Huebsch L; Allan D; Atkins H; Anstee G; Sabloff M; Scrivens N; Maze D; Bredeson C; Kekre N
Biol Blood Marrow Transplant; 2017 Dec; 23(12):2096-2101. PubMed ID: 28821454
[TBL] [Abstract][Full Text] [Related]
16. Donor Type and Disease Risk Predict the Success of Allogeneic Hematopoietic Cell Transplantation: A Single-Center Analysis of 613 Adult Hematopoietic Cell Transplantation Recipients Using a Modified Composite Endpoint.
Solh M; Zhang X; Connor K; Brown S; Morris LE; Holland HK; Bashey A; Solomon SR
Biol Blood Marrow Transplant; 2017 Dec; 23(12):2192-2198. PubMed ID: 28864140
[TBL] [Abstract][Full Text] [Related]
17. Fecal calprotectin and α1-antitrypsin dynamics in gastrointestinal GvHD.
O'Meara A; Kapel N; Xhaard A; Sicre de Fontbrune F; Manéné D; Dhedin N; de Latour RP; Socié G; Robin M
Bone Marrow Transplant; 2015 Aug; 50(8):1105-9. PubMed ID: 25961766
[TBL] [Abstract][Full Text] [Related]
18. Fecal calprotectin in allogeneic stem cell transplantation for the diagnosis of acute intestinal graft versus host disease.
Bastos Oreiro M; Castilla-Llorente C; de la Guía AL; de Paz R; Van Domselaar M; Nieto J; Rodriguez A; Gallardo D; Canales M;
Bone Marrow Transplant; 2012 Sep; 47(9):1241-2. PubMed ID: 22307017
[No Abstract] [Full Text] [Related]
19. NOD2/CARD15 single nucleotide polymorphism 13 (3020insC) is associated with risk of sepsis and single nucleotide polymorphism 8 (2104C>T) with herpes viruses reactivation in patients after allogeneic hematopoietic stem cell transplantation.
Jaskula E; Lange A; Kyrcz-Krzemien S; Markiewicz M; Dzierzak-Mietla M; Jedrzejczak WW; Czajka P; Mordak-Domagala M; Lange J; Gronkowska A; Nowak J; Warzocha K; Hellmann A; Kowalczyk J; Drabko K; Gozdzik J; Mizia S;
Biol Blood Marrow Transplant; 2014 Mar; 20(3):409-14. PubMed ID: 24345423
[TBL] [Abstract][Full Text] [Related]
20. Gut toxicity during hemopoietic stem cell transplantation may predict acute graft-versus-host disease severity in patients.
Johansson JE; Ekman T
Dig Dis Sci; 2007 Sep; 52(9):2340-5. PubMed ID: 17415646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
